Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
6.84
+0.08 (1.18%)
At close: Feb 4, 2026
Hunan Hansen Pharmaceutical Company Description
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally.
The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms.
Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.
Hunan Hansen Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1998 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,675 |
| CEO | Zhengqing Liu |
Contact Details
Address: No. 2688, Yincheng Avenue Yiyang, 413000 China | |
| Phone | 86 73 7635 1006 |
| Website | hansenzy.com |
Stock Details
| Ticker Symbol | 002412 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000PK2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhengqing Liu | Chairman and Chief Executive Officer |
| Jianghong Dai | Vice President, Chief Financial Officer and Board Secretary |
| Hua Yang | Vice President and MD of Hansen Research |
| Lingsong Ao | Director and Vice President |
| Jianjun Fu | Director and Vice President |
| Ai Hua Liu | Vice President |
| Zhijun Liu | Vice President |
| Zhirong Guo | Accounting Supervisor |